Throughout this hour-long panel discussion, CAP experts will explain the changes by the Centers for Medicare & Medicaid Services (CMS) in the 2017 Medicare Physician Fee Schedule. Expected to be published by the CMS in late October, the fee schedule contains Medicare reimbursement and policy changes affecting pathologists.
In July, the CMS provided detail on its intention to revalue certain pathology services targeted as potentially misvalued. For 2017, the CMS proposed increases for:
- Pathology add-on services
- Microslide consultations
- Prostate biopsy, any method G-code
- Tumor immunohistochemistry
The CMS also proposed decreases in the physician work and practice expense for some services, such as flow cytometry.
During the webinar presentation, CAP experts will discuss how the final rule affects Medicare reimbursement for pathology services and the CAP's advocacy efforts to impact these changes. The second part of the webinar will be a question-and-answer session.
Patrick Godbey, MD, FCAP
Jonathan Myles, MD, FCAP
Mark Synovec, MD, FCAP
John Scott, VP of CAP Policy and Advocacy